A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19

BACKGROUND: The nitazoxanide plus atazanavir/ritonavir for COVID-19 (NACOVID) trial investigated the efficacy and safety of repurposed nitazoxanide combined with atazanavir/ritonavir for COVID-19. METHODS: This is a pilot, randomized, open-label multicenter trial conducted in Nigeria. Mild to modera...

Descripción completa

Detalles Bibliográficos
Autores principales: Fowotade, Adeola, Bamidele, Folasade, Egbetola, Boluwatife, Fagbamigbe, Adeniyi F., Adeagbo, Babatunde A., Adefuye, Bolanle O., Olagunoye, Ajibola, Ojo, Temitope O., Adebiyi, Akindele O., Olagunju, Omobolanle I., Ladipo, Olabode T., Akinloye, Abdulafeez, Onayade, Adedeji, Bolaji, Oluseye O., Rannard, Steve, Happi, Christian, Owen, Andrew, Olagunju, Adeniyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493023/
https://www.ncbi.nlm.nih.gov/pubmed/36160134
http://dx.doi.org/10.3389/fmed.2022.956123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493023/
https://www.ncbi.nlm.nih.gov/pubmed/36160134
http://dx.doi.org/10.3389/fmed.2022.956123

Ejemplares similares